In a variety of epithelial cancers, SDC-1 expression is reduced or totally lost with tumor progression and aggressive phenotype [53], [54], [55], [56], [57] and low SDC-1 expression was shown to be associated with poor prognostic outcome and shorter survival [54], [56], [58], [59], [60]. This evidence concerns the gene SDC1 and neoplasm.